
In the fourth of a monthly FDA-focused blog published exclusively by The Pharma Letter, Dr Nicola Davies looks at the history of the FDA in the historic Shirley Amendment.
Today, new applications for marketable drugs undergo a strict, lengthy, all-encompassing process of testing for safety and efficacy. The US Food and Drug Administration stands as a prime example of an agency that stringently conducts and/or oversees this process. However, it was only a hundred years ago that the USA was plagued by a plethora of ‘snake oil salesmen,’ and the government of the day was beginning its long and arduous battle to bring control and transparency to the new-found booming drug trade. Various potions, oils, powders and ointments were for sale as a remedy for every illness or malady imaginable – some being marketed as a panacea or cure-all. Not only were peddlers selling a cornucopia of ‘medicines’ using unverified claims that often had no basis in reality, but some of these ‘medicines’ were dangerous and even lethal.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze